Energenesis Biomedical CO.,LTD. (6657.TW)
TWD 51.8
(-4.25%)
TWD 51.8
(-4.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -225.04 Million | -232.84 Million | -97.28 Million | -98.91 Million | -121.2 Million |
| Net Income | -260.38 Million | -265.66 Million | -120.23 Million | -129.47 Million | -149.77 Million |
| Depreciation & Amortization | 23.82 Million | 24.41 Million | 22.9 Million | 19.97 Million | 17.85 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 14.87 Million | 11.09 Million | 4.91 Million | 6.9 Million | 10.51 Million |
| Change in working capital | -2.51 Million | -2.66 Million | -5.32 Million | 3.62 Million | -819 Thousand |
| Other non-cash items | -842 Thousand | -3.68 Million | -1.78 Million | -3.01 Million | -2.08 Million |
| Investing Cash Flow | -58.95 Million | 175.41 Million | -115.76 Million | 59.44 Million | -244.07 Million |
| Investments in PPE | -844 Thousand | -6.58 Million | -8.89 Million | -4.63 Million | -1.93 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | -226 Million | -464 Million | -369 Million | -531 Million |
| Sales/Maturities of investments | - | 408 Million | 357 Million | 433 Million | 293 Million |
| Other Investing Activities | -58.11 Million | 4000.00 | 134 Thousand | 73 Thousand | -4.13 Million |
| Financing Cash Flow | 440.42 Million | -1.75 Million | 287.98 Million | 4.76 Million | 436.55 Million |
| Debt repayment | -6.51 Million | -6.5 Million | - | - | -34.73 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 4.75 Million | 294.64 Million | 9 Million | 473.28 Million |
| Other Financing Activities | 446.93 Million | -6.5 Million | 127 Thousand | - | - |
| Accounts receivables | 607 Thousand | -218 Thousand | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | -152 Thousand | 163 Thousand | -17 Thousand | 36 Thousand | -83 Thousand |
| Other working capital | -2.97 Million | -2.61 Million | - | - | - |
| Cash at beginning of period | 90.19 Million | 149.37 Million | 74.43 Million | 109.14 Million | 37.86 Million |
| Cash at end of period | 246.6 Million | 90.19 Million | 149.37 Million | 74.43 Million | 109.14 Million |
| Capital Expenditure | -844 Thousand | -6.58 Million | -8.89 Million | -4.63 Million | -1.93 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 156.41 Million | -59.17 Million | 74.93 Million | -34.7 Million | 71.28 Million |
| Free Cash Flow | -225.89 Million | -239.42 Million | -106.18 Million | -103.55 Million | -123.13 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -48.71 Million | -42.79 Million | -62.32 Million | -45.16 Million | -96.54 Million | -56.34 Million |
| Depreciation & Amortization | 5.69 Million | 5.73 Million | 5.87 Million | 5.89 Million | 6.01 Million | 6.04 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 3.77 Million | 2.5 Million | 4.06 Million | 696 Thousand | 7.36 Million | 2.74 Million |
| Change in working capital | -2.04 Million | -25.9 Million | 671 Thousand | -22.35 Million | 24.08 Million | -5.08 Million |
| Other non-cash items | -3.35 Million | -3.96 Million | -652 Thousand | -2.72 Million | -1.56 Million | -1.37 Million |
| Investing Cash Flow | -58.09 Million | 110.51 Million | 42.25 Million | 68.87 Million | -170.08 Million | - |
| Investments in PPE | -90 Thousand | - | -175 Thousand | -587 Thousand | -82 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -188.7 Million | -121.29 Million | - | -64.53 Million | -320 Million | - |
| Sales/Maturities of investments | 130.7 Million | 231.4 Million | - | 134 Million | 150 Million | - |
| Other Investing Activities | -58 Million | 400 Thousand | 42.42 Million | - | - | - |
| Financing Cash Flow | -1.56 Million | 5.89 Million | -1.12 Million | -563 Thousand | 443.74 Million | -1.63 Million |
| Debt repayment | -1.56 Million | - | -1.62 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 7.45 Million | - | 1.05 Million | 445.38 Million | - |
| Other Financing Activities | -1.56 Million | - | 501 Thousand | - | - | - |
| Accounts receivables | 248 Thousand | - | -31 Thousand | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 115 Thousand | 48 Thousand | -89 Thousand | 72 Thousand | -14 Thousand | -121 Thousand |
| Other working capital | -2.26 Million | - | 791 Thousand | - | - | - |
| Cash at beginning of period | 302.19 Million | 246.6 Million | 257.85 Million | 250.28 Million | 35.85 Million | 90.19 Million |
| Cash at end of period | 201.06 Million | 302.19 Million | 246.6 Million | 257.85 Million | 250.28 Million | 35.85 Million |
| Capital Expenditure | -90 Thousand | - | -175 Thousand | -587 Thousand | -82 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -101.12 Million | 55.58 Million | -11.24 Million | 7.56 Million | 214.43 Million | -54.33 Million |
| Free Cash Flow | -41.55 Million | -60.82 Million | -52.54 Million | -61.33 Million | -59.3 Million | -52.7 Million |
WISE
5272
9845
SKF-A
4150
RQHTF